When viewing this topic in a different language, you may notice some differences in the way the content is structured, but it still reflects the latest evidence-based guidance.

Pulmonary regurgitation

Evidence last reviewed: 28 Mar 2026
Topic last updated: 15 Mar 2024

Summary

Definition

History and exam

Key diagnostic factors

  • presence of risk factors
Full details

Other diagnostic factors

  • dyspnoea
  • decreased exercise tolerance
  • diastolic murmur
  • orthopnoea
  • paroxysmal nocturnal dyspnoea
  • palpitations
  • fatigue
  • diaphoresis
  • displaced point of maximal apical impulse
  • systolic murmur
  • signs of right-sided heart failure
Full details

Risk factors

  • pulmonary hypertension
  • surgical repair of tetralogy of Fallot, pulmonary stenosis, or pulmonary atresia
  • endocarditis
  • left-sided heart disease
  • previous Ross procedure (with prosthetic pulmonary valve, homograft valve replacement)
  • collagen vascular disease
  • malignancies that involve the main pulmonary artery
Full details

Diagnostic tests

1st tests to order

  • ECG
  • trans-thoracic Doppler echocardiogram (TTE)
  • CXR
Full details

Tests to consider

  • trans-oesophageal Doppler echocardiogram (TEE)
  • cardiac MRI
  • MRI chest
  • CT scan chest
Full details

Treatment algorithm

ACUTE

acute pulmonary regurgitation

ONGOING

chronic pulmonary regurgitation

Contributors

Authors

Karen K. Stout, MD, FACC

Professor of Medicine

Adjunct Professor of Pediatrics and Cardiology

Division of Cardiology

University of Washington

Seattle

WA

Disclosures

KKS is former chair of a prior ACC/AHA guidelines committee and an author of a guideline cited in this topic.

Andrew Pistner, MD

Assistant Professor of Medicine

Division of Cardiology

University of Washington

Seattle

WA

Disclosures

AP declares that he has no competing interests

Acknowledgements

Dr Karen K. Stout and Dr Andrew Pistner would like to gratefully acknowledge Dr Sachin S. Goel, Dr Chetan P. Huded, Dr Samir Kapadia, and Dr Mehdi H. Shishehbor, previous contributors to this topic.

Disclosures

SSG, CPH, SK, and MHS declare that they have no competing interests.

Peer reviewers

Satish Adwani, MD

Consultant in Paediatric Cardiology and Adults with Congenital Heart Disease

John Radcliffe Hospital

Oxford

UK

Disclosures

SA declares that he has no competing interests.

Sarabjeet Singh, MD

Cardiology Fellow

Adult Cardiovascular Fellowship

Department of Cardiology

Chicago Medical School (CMS) and affiliated hospitals

Chicago

IL

Disclosures

SS declares that he has no competing interests.

Debabrata Mukherjee, MD

Gill Foundation Professor of Interventional Cardiology

Director of Cardiac Catheterization Laboratories

Gill Heart Institute

Division of Cardiovascular Medicine

University of Kentucky

Lexington

KY

Declarações

DM declares that he has no competing interests.

Syed Wamique Yusuf, MD, MRCPI, FACC

Associate Professor

University of Texas MD Anderson Cancer Center

Department of Cardiology

Houston

TX

Declarações

SWY declares that he has no competing interests.

Créditos aos pareceristas

Os tópicos do BMJ Best Practice são constantemente atualizados, seguindo os desenvolvimentos das evidências e das diretrizes. Os pareceristas aqui listados revisaram o conteúdo pelo menos uma vez durante a história do tópico.

Declarações

As afiliações e declarações dos pareceristas referem--se ao momento da revisão.

Referências

Nossas equipes internas de editoria e de evidências trabalham em conjunto com colaboradores internacionais especializados e pares revisores para garantir que forneçamos acesso às informações o mais clinicamente relevantes possível.

Principais artigos

American College of Radiology. ACR appropriateness criteria: congenital or acquired heart disease​. 2023 [internet publication].Texto completo

Stout KK, Daniels CJ, Aboulhosn JA, et al. 2018 AHA/ACC guideline for the management of adults with congenital heart disease: a report of the American College of Cardiology/American Heart Association Task Force on clinical practice guidelines. J Am Coll Cardiol. 2019 Apr 2;73(12):e81-192.Texto completo  Resumo

Baumgartner H, De Backer J, Babu-Narayan SV, et al. 2020 ESC guidelines for the management of adult congenital heart disease. Eur Heart J. 2021 Feb 11;42(6):563-645.Texto completo  Resumo

Bokma JP, Geva T, Sleeper LA, et al. Improved outcomes after pulmonary valve replacement in repaired tetralogy of Fallot. J Am Coll Cardiol. 2023 May 30;81(21):2075-85.Texto completo  Resumo

Writing Committee Members, Otto CM, Nishimura RA, et al. 2020 ACC/AHA guideline for the management of patients with valvular heart disease: a report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines. J Am Coll Cardiol. 2021 Feb 2;77(4):e25-197.Texto completo  Resumo

Artigos de referência

Uma lista completa das fontes referenciadas neste tópico está disponível para os usuários com acesso total ao BMJ Best Practice.
  • Pulmonary regurgitation images
  • Diagnósticos diferenciais

    • Mitral stenosis
    • Aortic regurgitation (AR)
    • Atrial myxoma
    Mais Diagnósticos diferenciais
  • Guidelines

    • ACR appropriateness criteria: known or suspected congenital heart disease
    • 2020 ACC/AHA guideline for the management of patients with valvular heart disease
    Mais Guidelines
  • Patient information

    Heart failure

    Heart failure: how can I help myself?

    More Patient information
  • Videos

    Pulmonary regurgitation

    More videos
  • padlock-lockedLog in or subscribe to access all of BMJ Best Practice

Use of this content is subject to our disclaimer